Good Life Meds Review

What Good Life Meds charges

• Semaglutide: $199/mo — a one-month supply; a $99 hero figure requires a checkout promotion code the page excludes from its own pricing
• Tirzepatide: $297/mo — per month; a quarter is $822, six months is $1,494, and a new-patient twelve-week supply is $599
• Sermorelin: $124 — the page names no supply period; the product carries a coming-soon badge and a $99 first-order promotion
• NAD+: $124 — the page names no supply period; the product carries a coming-soon badge and a $99 first-order promotion
• Glutathione: $99 — the page names no supply period; the product carries a coming-soon badge and an $80 first-order promotion

Four badges that say passed, and nothing that shows it

Potency, sterility, pH and endotoxicity each render as a green badge reading passed on every product page.

The accompanying claim is that "Every batch is fully tested in full chemistry and microbiology labs at the pharmacy facility", and no certificate is reachable from any of those badges.

A badge that reports a result without publishing it is a testing claim. It is recorded here as a claim and nothing more.

The absent sentence is the notable one

Its own words on sourcing are that its "medications are sourced directly from a US-based and Licensed Pharmacies to ensure the highest standards of safety, consistency, and quality in compounded GLP formulations".

Nowhere on the pages read does it say that its compounded products are not FDA-approved, which most sellers in the same batch do state.

Its "FDA approved for weight loss" line was traced in document order and attaches to the branded cards for Wegovy, Zepbound and Mounjaro, not to anything it compounds.

The hero figures are promotion codes, and the page admits it

Its headline offers require a code entered at checkout, and the page itself says "Pricing below DOES NOT include any promotional offers."

Only the standing rates are filed here; the hero figures are not, because a code is a condition a reader may not meet.

Its semaglutide is charged at one rate across every dose level, which removes the usual trap of a floor that only applies at the lowest dose.

Its peptide pages are not finished

Sermorelin, NAD+ and glutathione each carry a coming-soon or limited-quantity badge and print no supply period beside the figure.

Without a supply period, those numbers cannot be compared against a seller that publishes a monthly rate.

Its coverage statement is a count with no list behind it, so no fifty-state claim is credited here.

How we verified this

• Read the four test badges in place and confirmed no certificate is reachable from any of them, then recorded the testing as a claim.
• Traced the FDA-approval line in document order to the branded cards it sits beside, and confirmed no non-approval statement appears anywhere on the pages read.
• Excluded the promotional hero figures because the page's own pricing note excludes them, and filed the standing rates instead.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Screened the brand, both named pharmacies and its medical group against the live federal warning-letter table through a matcher that normalises both the query and the filed company name before comparing, pulling all 3,677 records in pages and filtering locally because the table's own search parameter is ignored, with a positive and a nonsense control in the same run.